Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma
Clinical, Cosmetic and Investigational Dermatology Jan 10, 2018
Badawi AM, et al. - This study encompassed an inspection of the efficacy and safety of fractional erbium-doped yttrium aluminum garnet (Er:YAG) laser as an assisted drug delivery for enhancing topical hydroquinone (HQ) permeation into the skin of melasma patients. The inference drawn was that ablative fractional laser (AFL)-assisted delivery of hydroquinone (HQ) was a safe and effective technique for the treatment of melasma.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries